Nothing Special   »   [go: up one dir, main page]

IN2013MU03421A - - Google Patents

Info

Publication number
IN2013MU03421A
IN2013MU03421A IN3421MU2013A IN2013MU03421A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A IN 3421MU2013 A IN3421MU2013 A IN 3421MU2013A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
cefepime
stereoisomer
Prior art date
Application number
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to EP14811971.2A priority Critical patent/EP3062794B1/en
Priority to US15/030,061 priority patent/US20160271118A1/en
Priority to PCT/IB2014/065708 priority patent/WO2015063714A1/en
Priority to IN3421MU2013 priority patent/IN2013MU03421A/en
Publication of IN2013MU03421A publication Critical patent/IN2013MU03421A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions comprising: (a) a beta-lactam compound selected from sulbactam, cefepime or a pharmaceutically acceptable derivative thereof, and (b) a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
IN3421MU2013 2013-10-30 2014-10-30 IN2013MU03421A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP14811971.2A EP3062794B1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents
US15/030,061 US20160271118A1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents
PCT/IB2014/065708 WO2015063714A1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents
IN3421MU2013 IN2013MU03421A (en) 2013-10-30 2014-10-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3421MU2013 IN2013MU03421A (en) 2013-10-30 2014-10-30

Publications (1)

Publication Number Publication Date
IN2013MU03421A true IN2013MU03421A (en) 2015-07-17

Family

ID=52023565

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3421MU2013 IN2013MU03421A (en) 2013-10-30 2014-10-30

Country Status (4)

Country Link
US (1) US20160271118A1 (en)
EP (1) EP3062794B1 (en)
IN (1) IN2013MU03421A (en)
WO (1) WO2015063714A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501464B2 (en) 2015-12-11 2019-12-10 Wockhardt Limited 7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide containing compounds and their use in treating bacterial infections
CN110352194A (en) * 2017-03-02 2019-10-18 沃克哈特有限公司 Heterocyclic derivatives as antibacterial compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5808860B2 (en) * 2011-07-26 2015-11-10 ウォックハート リミテッド Pharmaceutical composition comprising sulbactam and beta-lactamase inhibitor
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
ES2672100T3 (en) * 2012-08-25 2018-06-12 Wockhardt Limited 1,6-diazabicyclo [3,2,1] octane-7-one derivatives and their use in the treatment of bacterial infections

Also Published As

Publication number Publication date
EP3062794B1 (en) 2018-09-26
WO2015063714A1 (en) 2015-05-07
EP3062794A1 (en) 2016-09-07
US20160271118A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
MX2018002986A (en) Heteroaryl compounds as irak inhibitors and uses thereof.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2017004200A (en) Heteroaryl compounds as btk inhibitors and uses thereof.
MX2018001990A (en) Compositions comprising a pi3k inhibitor and an hdac inhibitor.
NZ746825A (en) Oxysterols and methods of use thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
MX2016013431A (en) Pharmaceutical compositions comprising antibacterial agents.
MX2017016619A (en) Pyrimidine derivatives as btk inhibitors and uses thereof.
MX2015015562A (en) Dihydropyridinone mgat2 inhibitors.
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
MX2018014813A (en) Antibacterial compositions.
MX2016001138A (en) Tricyclic benzoxaborole compound, preparation method therefor, and use thereof.
MX2018004304A (en) Quinoxaline and pyridopyrazine derivatives as pi3kbeta inhibitors.
IN2013MU03421A (en)
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
IN2013MU03704A (en)
IN2013MU03422A (en)
IN2013MU03309A (en)
IN2014MU00859A (en)
IN2013MU03308A (en)
IN2014MU01194A (en)